company background image
RNLX.Y logo

Renalytix OTCPK:RNLX.Y Stock Report

Last Price

US$0.17

Market Cap

US$19.8m

7D

11.7%

1Y

-83.9%

Updated

29 Oct, 2024

Data

Company Financials +

Renalytix Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Renalytix
Historical stock prices
Current Share PriceUK£0.17
52 Week HighUK£2.40
52 Week LowUK£0.12
Beta2.1
11 Month Change-35.87%
3 Month Change-62.69%
1 Year Change-83.86%
33 Year Change-99.33%
5 Year Changen/a
Change since IPO-98.76%

Recent News & Updates

Recent updates

Renalytix: The Investment Case Is Shot

Jul 25

Renalytix AI GAAP EPS of -$0.20, revenue of $0.81M

Jun 30

Renalytix: High Growth Artificial Intelligence Play, Nearing A Possible Breakout

Apr 05

Renalytix: Laying The Foundations For Growth

Jan 05

Renalytix: Building Out A Capability To Ramp Revenue

Oct 20

Renalytix AI EPS beats by $0.06, misses on revenue

Jun 15

Centers for Medicaid & Medicare establishes MICT pathway

Jan 13

Exact and Exact Sciences trade higher; Seen as beneficiaries from new CMS rule

Jan 12

Shareholder Returns

RNLX.YUS Healthcare ServicesUS Market
7D11.7%-3.0%-0.4%
1Y-83.9%7.6%39.5%

Return vs Industry: RNLX.Y underperformed the US Healthcare Services industry which returned 7.6% over the past year.

Return vs Market: RNLX.Y underperformed the US Market which returned 39.5% over the past year.

Price Volatility

Is RNLX.Y's price volatile compared to industry and market?
RNLX.Y volatility
RNLX.Y Average Weekly Movement15.6%
Healthcare Services Industry Average Movement10.4%
Market Average Movement6.1%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market3.0%

Stable Share Price: RNLX.Y's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: RNLX.Y's weekly volatility has decreased from 41% to 16% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2018n/aJames McCulloughrenalytix.com

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix Plc Fundamentals Summary

How do Renalytix's earnings and revenue compare to its market cap?
RNLX.Y fundamental statistics
Market capUS$19.76m
Earnings (TTM)-US$33.46m
Revenue (TTM)US$2.29m

8.6x

P/S Ratio

-0.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RNLX.Y income statement (TTM)
RevenueUS$2.29m
Cost of RevenueUS$2.13m
Gross ProfitUS$156.00k
Other ExpensesUS$33.61m
Earnings-US$33.46m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.18
Gross Margin6.82%
Net Profit Margin-1,461.60%
Debt/Equity Ratio-108.1%

How did RNLX.Y perform over the long term?

See historical performance and comparison